Human Ehrlichiosis
Ehrlichiosis caused by gram negative, obligately intracellular bacteria belonging to the genus Ehrlichia of the family Anaplasmataceae, Order Rickettsiales and the alpha sub-division Proteobacteria. Though they have a characteristic Gram negative cell wall structure, they lack the important enzymes to synthesize cell membrane components likewise lipopolysaccharide and peptidoglycan. As intracellular pathogens, Ehrlichia reside in cytoplasmic membrane-bound vacuoles inside host cells by forming microcolonies called morulae, which is derived from the Latin word “morus” for mulberry. Morulae range 1.0 to 6.0 µm in diameter which may contain uniform or mixed cell types.
- Vectors and reservoirs
- Clinical manifestations
- Treatment
Related Conference of Human Ehrlichiosis
5th International conference on Vaccines, Vaccination and Immunization
19th International Conference on Allergy and Clinical Immunology
5th International Conference on Immunology And Immunotherapy
Human Ehrlichiosis Conference Speakers
Recommended Sessions
Related Journals
Are you interested in
- Advances in Molecular Immunology - ALLERGY 2024 (France)
- Allergen Identification and Characterization - ALLERGY 2024 (France)
- Biomarkers for Allergy Diagnosis and Treatment - ALLERGY 2024 (France)
- Case Studies in Allergy Diagnosis and Management - ALLERGY 2024 (France)
- Clinical Trials and Translational Research in Allergy and Immunology - ALLERGY 2024 (France)
- Digital Health and Telemedicine in Allergy Care - ALLERGY 2024 (France)
- Epidemiology and Population Studies in Allergic Diseases - ALLERGY 2024 (France)
- Immune Responses to Vaccination - ALLERGY 2024 (France)
- Immunogenetics and Allergic Susceptibility - ALLERGY 2024 (France)
- Immunological Aspects of Drug Allergies - ALLERGY 2024 (France)
- Immunological Basis of Food Allergy - ALLERGY 2024 (France)
- Immunological Mechanisms in Autoimmune Diseases - ALLERGY 2024 (France)
- Immunomodulation in Allergy Management - ALLERGY 2024 (France)
- Immunopathogenesis of Allergic Diseases - ALLERGY 2024 (France)
- Immunotherapy for Allergic Conditions - ALLERGY 2024 (France)
- Inflammatory Pathways in Asthma and Allergic Rhinitis - ALLERGY 2024 (France)
- Mechanisms of Immunodeficiency Diseases - ALLERGY 2024 (France)
- Novel Therapeutic Approaches for Allergic Disorders - ALLERGY 2024 (France)
- Role of Microbiota in Allergic Disorders - ALLERGY 2024 (France)